Key Takeaways
- Insulin resistance can occur at a normal weight, affecting approximately 27% (95% CI 18–36% of normal-BMI adults
- Common signs and symptoms may include dark skin patches, fatigue after meals, irregular periods, and difficulty losing weight
- BMI alone does not capture metabolic health; body fat distribution and waist circumference can provide additional information about metabolic risk
- South Asian populations are particularly susceptible to insulin resistance at lower BMIs
- Tests like HOMA-IR can help assess insulin resistance before blood sugar levels rise
You may assume insulin resistance only affects those who are overweight, but insulin resistance in normal-weight individuals is a real and well-documented condition. The Centers for Disease Control and Prevention confirms that you cannot determine insulin resistance simply by looking at someone, as overweight and obesity are risk factors, not requirements[1]. This means many normal-weight individuals may experience symptoms without realising the underlying cause. This article explores how insulin resistance can develop despite a healthy BMI, what symptoms to watch for, and why metabolic testing matters more than the number on your scale.
What is insulin resistance?
Insulin resistance occurs when your body's cells do not respond effectively to insulin, a hormone that helps glucose enter cells for energy. When cells become resistant, the pancreas compensates by producing more insulin, leading to elevated insulin levels in the blood (hyperinsulinaemia). This process primarily affects the liver, skeletal muscles, and fat tissue[2].
Over time, insulin resistance can set the stage for prediabetes and type 2 diabetes. Unlike type 1 diabetes, which involves an autoimmune process where the body produces insufficient insulin, type 2 diabetes develops gradually as insulin resistance worsens[1].
This article provides general education and is not intended for diagnosing or interpreting individual test results.
Can you be insulin resistant at a normal weight?
Yes, research confirms that insulin resistance without obesity is more common than many people realise. A meta-analysis of over 400,000 individuals with normal BMI found that approximately 26.78% had metabolic disorders, qualifying them as "metabolically-obese normal-weight" (MONW)[3].
The prevalence may be even higher in certain populations. A nationally representative ICMR-INDIAB study found that 43.3% of Indian adults had metabolic abnormalities despite a BMI below 25 kg/m²[4]. These findings highlight that BMI alone may not fully reflect a person's metabolic health.
Symptoms of insulin resistance at a normal weight
Many insulin resistance symptoms in normal-weight individuals are subtle and easily overlooked. Here are the key signs to watch for:
- Skin changes: Acanthosis nigricans, characterised by dark, velvety patches of skin in body folds such as the neck, armpits, and groin, is commonly associated with insulin resistance[5]. This may be the only visible indicator in some individuals.
- Metabolic indicators: The metabolic consequences of insulin resistance can include elevated blood pressure, abnormal cholesterol levels (dyslipidaemia), raised uric acid, and increased inflammatory markers[2].
- Hormonal symptoms in women: Women may experience ovarian dysfunction and signs of excess androgens, including hirsutism (excess facial or body hair), polycystic ovaries, and irregular menstrual cycles[6]. These symptoms may be the primary clinical manifestation of insulin resistance in women.
Other commonly reported symptoms include fatigue after meals, difficulty losing weight despite diet and exercise, and skin tags.
Why BMI doesn't tell the whole story
Body mass index (BMI) is widely used but does not fully capture metabolic risk. This limitation is particularly significant for South Asians, who tend to develop insulin resistance at lower BMI values compared to other populations[7].
Visceral fat matters more
Research shows that visceral fat (fat stored around internal organs) has the greatest predictive value for insulin resistance compared with BMI, waist circumference, or body fat percentage. The study found visceral fat had an AUC (area under the curve) of 0.690 versus 0.570 for body fat percentage, indicating higher predictive value in this study[8].
This explains why someone with a normal BMI but high visceral fat, sometimes called "thin outside, fat inside" (TOFI), may still have insulin resistance symptoms and metabolic dysfunction[9].
What causes insulin resistance at a normal weight?
Several factors can contribute to normal weight insulin resistance:
- Ethnicity and genetic factors: A study comparing Asian Chinese and Caucasian European adults found that the Chinese participants had higher visceral fat levels and several less favourable metabolic markers, despite matching for age, sex, and BMI. These differences included higher fasting glucose, insulin, triglycerides, and liver enzyme levels[9].
- Body fat distribution: Where your body stores fat can also affect metabolic risk. Individuals who accumulate fat around the abdomen and internal organs face higher metabolic risk, even with normal overall weight[8].
- Associated conditions: Risk factors for insulin resistance include being aged 35 or older and having conditions such as polycystic ovary syndrome (PCOS)[10]. Women with PCOS can experience insulin resistance independent of their weight due to hormonal factors[6].
- Lifestyle factors: Physical inactivity, poor sleep quality, and chronic stress may also contribute to reduced insulin sensitivity in normal-weight individuals.
Consult your healthcare provider for personalised assessment of your risk factors.
How is insulin resistance diagnosed at a normal weight?
Diagnosing insulin resistance in normal-weight individuals requires looking beyond standard glucose tests.
HOMA-IR testing
The Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) is a commonly used calculation that evaluates the relationship between fasting glucose and fasting insulin levels. A HOMA-IR value of 2.5 or above typically indicates insulin resistance in clinical settings[11].
Why glucose alone isn't enough
Fasting glucose can remain below 100 mg/dL for years despite elevated fasting insulin levels. This happens because the pancreas compensates by producing more insulin to maintain normal blood sugar. Higher HOMA-IR has been associated with hyperinsulinaemia even when glucose tests appear normal[12].
Additional tests may include fasting insulin levels, lipid profiles, and waist-to-hip ratio measurements.
Test interpretation should always be done by a qualified healthcare provider.
Conclusion
Insulin resistance can affect individuals at any weight, making symptoms and metabolic testing more reliable indicators than BMI alone. Recognising signs such as dark skin patches, fatigue after meals, or irregular periods may prompt earlier investigation. If you belong to a high-risk population, such as those of South Asian descent, or have conditions like PCOS, discussing metabolic screening with your doctor can help identify insulin resistance before it progresses. Lifestyle modifications, including regular physical activity and balanced nutrition, remain the foundation for improving insulin sensitivity.
FAQs
Can you have insulin resistance with normal blood sugar?
Yes, your pancreas may compensate for insulin resistance by producing more insulin, keeping blood sugar normal for years. Tests like HOMA-IR can detect elevated insulin levels before glucose rises.
What are the very first signs of insulin resistance?
Early signs may include dark, velvety skin patches on the neck or armpits (acanthosis nigricans), fatigue after eating, skin tags, and difficulty losing weight despite healthy habits.
Is "skinny fat" a real medical condition?
Yes, medically termed "metabolically unhealthy normal weight" (MUNW) or TOFI (thin outside, fat inside). Research suggests this affects approximately 27% of normal-weight adults.
Can insulin resistance in normal-weight people be reversed?
Yes, lifestyle changes including regular exercise (150 minutes per week), dietary improvements, and modest weight loss can significantly improve insulin sensitivity and reduce diabetes risk.
Does PCOS cause insulin resistance even at a normal weight?
Yes, women with PCOS can experience insulin resistance regardless of BMI due to hormonal factors affecting how their bodies respond to insulin.
Should a normal-weight person get tested for insulin resistance?
Consider testing if you have risk factors such as South Asian ethnicity, PCOS, family history of diabetes, symptoms like acanthosis nigricans, or are aged 35 or older. Discuss with your healthcare provider.
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. The information provided should not be used for diagnosing or treating health conditions. Always consult a qualified healthcare provider for diagnosis, treatment, and personalised medical advice. Do not disregard professional medical advice or delay seeking it because of information found in this article. If you have a medical emergency, contact your doctor or emergency services immediately.
References
Centers for Disease Control and Prevention. (2024). About insulin resistance and type 2 diabetes. CDC. https://www.cdc.gov/diabetes/about/insulin-resistance-type-2-diabetes.html
Freeman, A. M., & Pennings, N. (2023). Insulin resistance. StatPearls [Internet]. https://pubmed.ncbi.nlm.nih.gov/29939616/
Zenas-Trujillo, G. Z., Trujillo-Ramirez, I., Carhuavilca-Torres, J. M., Ayala-Mendivil, R. E., & Vera-Ponce, V. J. (2023). Prevalence of metabolically-obese normal-weight worldwide: Systematic review and meta-analysis. Journal of Endocrinology and Metabolism, 13(3), 104-113. https://doi.org/10.14740/jem882
Deepa, M., Pradeepa, R., Venkatesan, U., Adhikari, P., Das, H. K., Dash, K., Mokta, J. K., Ningomban, S., Luaia, R., Budnah, R. O., Bhansali, A., Jampa, L., Suokhrie, V., Jain, S. M., Joshi, P. P., Joshi, S., Purty, A. J., Tobgay, K. J., Reang, T., … ICMR-INDIAB Collaborative Study Group. (2025). High prevalence of metabolic obesity in India: The ICMR-INDIAB national study (ICMR-INDIAB-23). The Indian Journal of Medical Research, 161, 461–472. https://doi.org/10.25259/ijmr_328_2025
